Latest issue of Hampshire & IOW Medicines Optimisation Bulletin

The latest bulletin contains information on the following:

• MHRA drug safety update: Short-acting beta 2 agonists (SABA) (salbutamol and terbutaline): reminder of the risks from overuse in asthma and to be aware of changes in the SABA prescribing guidelines
• MHRA drug safety update: Fezolinetant▼(Veoza): risk of liver injury; new recommendations to minimise risk
• Locally Commissioned Service (LCS) for Inclisiran (Leqvio®)
• SPS: Developing opioid safety across a system
• Guidance on shared care agreements with unregulated providers for children and young people with gender incongruence
• Early and locally advanced breast cancer: diagnosis and management – updated guidance (NG101)
• UKHSA launches campaign to tackle misconceptions on antibiotics

Download the bulletin here for more information and links:

• https://cpsc.org.uk/download_file/view/5125/3465